News and Analysis

Bacteriophage therapies re-enter clinical trials

After decades of delays, biotechs hope that bacteria-attacking viruses could provide an alternative to traditional antibiotics.

  • Subscribe to Nature Reviews Drug Discovery for full access:

    $265

    Subscribe

Additional access options:

Already a subscriber?  Log in  now or  Register  for online access.

Authors

  1. Search for Katie Kingwell in: